8th Annual Next Generation Sequencing Congress 2016

Over 450 senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions, nutrition companies as well as leading pharmaceutical and biotech companies

Over 60 case studies and presentations focused on the developments in NGS technologies and platforms, NGS data management as well as clinical applications & diagnostics of NGS

Including 3 interactive streams:

  • Advances In NGS Platforms And Key Therapeutic Applications
  • NGS Data Management And Bioinformatics
  • NGS Clinical Applications & Diagnostics

Co-located with the highly anticipated 4th Annual Single Cell Analysis Congress & 2nd Annual Genome Editing Congress

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the 8th Annual Next Generation Sequencing Congress, taking place on 10-11 November 2016 at the Novotel London West in London, UK.

This highly prestigious event provides a unique opportunity for over 450 senior level experts to network about the current landscape of the industry and to facilitate high level scientific discussions in order to help the market going forward.

The next generation sequencing market represents a rapidly moving area of research. The industry is characterised by continuous improvements and developments aimed at affordable costs, improved efficiency & accuracy. Advancements in NGS technologies and platforms, improved NGS data analysis techniques as well as novel bioinformatics tools all underpin the industry’s unquestionable potential. It has also been highlighted that the global next generation sequencing market will reach $27.8 billion by 2022.

On day one this year’s revamped programme will cover advances in next generation sequencing platforms and key therapeutic applications. Presentations will extend to such vital research areas as improvements in DNA, RNA & protein sequencing technologies, latest gene editing techniques in NGS as well as case studies from utilising NGS in medicine and therapeutics.
A separate stream will be devoted to hot topic areas in NGS data management and bioinformatics. Delegates will have the unique opportunity to join discussions about the developments in NGS analysis technologies, integrating ‘omic’ data sets and Big Data and cloud computing strategies in NGS.

On day two highly distinguished speakers will address NGS clinical applications and diagnostics. Such key topic areas will be covered as case studies of using next generation sequencing in the clinic, novel technologies and platforms to analyse NGS data and integrating data sets. NGS for precision & personalised medicine will also be covered.

Building on the success of previous events, the Next Generation Sequencing Congress will once again be co-located with the 4th Annual Single Cell Analysis Congress and 2nd Annual Genome Editing Congress. The Single Cell Analysis Congress is a unique opportunity for single cell experts to look at single cell analysis applications and technologies in different therapeutics areas, single cell ‘omics case studies and overcoming challenges in sample preparation, bioinformatics and data analysis. The Genome Editing Congress will look at the latest genome editing technologies as well as the therapeutic applications of genome editing.

The Next Generation Sequencing Congress is part of the highly successful Genomics and Genetics Research Series. For more information on other events in the series, please see below:

Next Generation Sequencing Sponsors 2016:

Next Generation Sequencing Sponsors 2015:


Media Partners

Bio-Equip_logo_www.bio-equip.cn200Translation Logo200KCHM_I_5_2_logo200GenesBiosave200labiotech_eu_200bigTechNet_logo_web_ 200_dark200Epi logo200RNAbiology logo200LabBulletinwhite200KTRN_2015 logoAbsave200mnt_logo_white200KMGE mobile genetics logoPharmavoice200GENlogoCMYK_092313pharma logo high respharmavision_logo.200iptechex_pharmalicensingLabsave Logo